Cathy R. Smith - 13 Mar 2023 Form 4 Insider Report for Bright Health Group Inc. (NEUE)

Reporting relationship: CFO & CAO
Issuer ticker: NEUE
Reported as of: 13 Mar 2023
Net transaction value: -$45,669
SEC form: 4
Accepted by SEC: 15 Mar 2023, 20:54:41 UTC
Prior SEC filing: 09 Mar 2023
Next SEC filing: 21 Apr 2023
Source filing: View source filing
Reporting owner signature: /s/ Eric Halverson for Catherine R. Smith, Attorney-in-Fact

Key filing fact

Cathy R. Smith filed Form 4 for Bright Health Group Inc. (NEUE) on 15 Mar 2023.

Key facts

This page summarizes Cathy R. Smith's Form 4 filing for Bright Health Group Inc. (NEUE).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 15 Mar 2023, 20:54.

Change

Previous filing in this sequence was filed on 09 Mar 2023.
Current net transaction value: -$45,669.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BHG transaction

Common Stock

Sale

Transaction value: $45,669
Shares: -114,173
Change %: -28%
Price: $0.4000^*
Shares after: 289,157
Date: 13 Mar 2023
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These shares were sold by the reporting person to cover tax withholding obligations upon the vesting of restricted stock units and were not discretionary transactions by the reporting person.

Footnote F2

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.38 to $0.41 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.